Literature DB >> 2826441

Cloning and expression of the gene for the major excreted protein of transformed mouse fibroblasts. A secreted lysosomal protease regulated by transformation.

B R Troen1, D Ascherman, D Atlas, M M Gottesman.   

Abstract

The major excreted protein (MEP) of mouse fibroblast cells is the 39,000 Mr precursor to a lysosomal acid protease (cathepsin L) induced by malignant transformation, growth factors, and tumor promoters. We have cloned and characterized the gene for MEP from NIH-3T3 cells. This cosmid clone (pcosMMEP), containing the unique 12,000-base pair mouse MEP gene, has been transfected into monkey kidney (CV-1) cells and human epidermoid carcinoma (A431) cells. The stable A4MEP transfectants produce mouse MEP that is an active cathepsin which is secreted, glycosylated, and processed intracellularly to lower molecular weight forms as in the wild-type NIH-3T3 cells. The CVMEP cells (nontransformed phenotype) produce quantities of mouse MEP similar to that found in NIH-3T3 cells, whereas the A4MEP cells (transformed phenotype) produce greater amounts of MEP similar to the levels seen in Kirsten virus-transformed NIH-3T3 cells. The MEP mRNAs from both mouse cells and stably transfected human cells are the same size and have the same single major site for initiation of transcription, indicating that the cloned mouse MEP promoter is active in transfected cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2826441

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Characterization and expression of AmphiCL encoding cathepsin l proteinase from amphioxus Branchiostoma belcheri tsingtauense.

Authors:  Yongjun Wang; Shicui Zhang; Zhenhui Liu; Hongyan Li; Lei Wang
Journal:  Mar Biotechnol (NY)       Date:  2005 Jul-Aug       Impact factor: 3.619

2.  Inhibitor studies indicate that active cathepsin L is probably essential to its own processing in cultured fibroblasts.

Authors:  A Salminen; M M Gottesman
Journal:  Biochem J       Date:  1990-11-15       Impact factor: 3.857

Review 3.  The early and late processing of lysosomal enzymes: proteolysis and compartmentation.

Authors:  A Hasilik
Journal:  Experientia       Date:  1992-02-15

4.  Use of a cloned multidrug resistance gene for coamplification and overproduction of major excreted protein, a transformation-regulated secreted acid protease.

Authors:  S E Kane; B R Troen; S Gal; K Ueda; I Pastan; M M Gottesman
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

5.  Epidermal growth factor-dependent phosphorylation of the GGA3 adaptor protein regulates its recruitment to membranes.

Authors:  Satoshi Kametaka; Rafael Mattera; Juan S Bonifacino
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

6.  Characterization of human cathepsin L promoter and identification of binding sites for NF-Y, Sp1 and Sp3 that are essential for its activity.

Authors:  Didier Jean; Nathalie Guillaume; Raymond Frade
Journal:  Biochem J       Date:  2002-01-01       Impact factor: 3.857

7.  Cloning and characterization of anti-cathepsin L single chain variable fragment whose expression inhibits procathepsin L secretion in human melanoma cells.

Authors:  Nathalie Guillaume-Rousselet; Didier Jean; Raymond Frade
Journal:  Biochem J       Date:  2002-10-01       Impact factor: 3.857

8.  Cloning of a virulence factor of Entamoeba histolytica. Pathogenic strains possess a unique cysteine proteinase gene.

Authors:  S Reed; J Bouvier; A S Pollack; J C Engel; M Brown; K Hirata; X Que; A Eakin; P Hagblom; F Gillin
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

9.  Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in paediatric tumour cells. Effects of tumour cell proliferation modulators on gelatinolytic activity.

Authors:  R G de Veas; L Schweigerer; M A Medina
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

10.  Isolation and sequence of a cDNA for human pro-(cathepsin L).

Authors:  S Gal; M M Gottesman
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.